Skip to main content
SpringerLink
Log in

Human myocardial Na,K-ATPase concentration in heart failure

  • Part II: Cardiac Hypertrophy and Failure
  • Published:
Molecular and Cellular Biochemistry Aims and scope Submit manuscript

Abstract

The Na,K-ATPase is of major importance for active ion transport across the sarcolemma and thus for electrical as well as contractile function of the myocardium. Furthermore, it is receptor for digitalis glycosides. In human studies of the regulatory aspects of myocardial Na,K-ATPase concentration a major problem has been to obtain tissue samples. Methodological accomplishments in quantification of myocardial Na,K-ATPase using vanadate facilitated 3H-ouabain binding to intact samples have, however, made it possible to obtain reliable measurements on human myocardial necropsies obtained at autopsy as well as on biopsies of a wet weight of only 1–2 mg obtained during heart catheterisation. However, access to the ultimately, normal, vital myocardial tissue has come from the heart transplantation programs, through which myocardial samples from cardiovascular healthy organ donors have become available. In the present paper we evaluate the various values reported for normal human myocardial Na,K-ATPase concentration, its regulation in heart disease and the association with digitalization. Normal myocardial Na,K-ATPase concentration level is found to be 700 pmol/g wet weight. No major variations were found between or within the walls of the heart ventricles. During the first few years of life a marked decrease in myocardial Na,K-ATPase concentration is followed by a stable level obtained in early adulthood and normally maintained throughout life. In patients with enlarged cardiac x-ray silhouette a significant positive, linear correlation between left ventricular ejection fraction (EF) and Na,K-ATPase concentration was established. A maximum reduction in Na,K-ATPase concentration of 89% was obtained when EF was reduced to 20%. Generally, heart failure associated with heart dilatation, myocardial hypertrophy as well as ischaemic heart disease is associated with reductions in myocardial Na,K-ATPase concentration of around 25%. During digoxin treatment of heart failure patients a further reduction in functional myocardial Na,K-ATPase concentration of 15% has been found. Thus, the total reduction in functional myocardial Na,K-ATPase concentration in digitalised heart failure patients may well be of the magnitude 40%. In conclusion, it has become possible to quantify human myocardial Na,K-ATPase in health and disease. Revealed reductions are in heart failure of importance for contractile function, generation of arrhythmia and for digoxin treatment.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. Smith TW: Digitalis: Mechanisms of action and clinical use. N Engl J Med 318: 358–365, 1988

    PubMed  Google Scholar 

  2. Nørgaard A, Kjeldsen K, Hansen O, Clausen T, Larsen CG, Larsen FG: Quantification of the 3H-ouabain binding site concentration in human myocardium: A postmorten study. Cardiovasc Res 20: 428–435, 1986

    PubMed  Google Scholar 

  3. Nørgaard A, Bagger JP, Bjerregaard P, Baandrup U, Kjeldsen K, Thomsen PE: Relation of left ventricular function and Na,K-pump concentration in suspected idiopathic dilated cardiomyopathy. Am J Cardiol 61: 1312–1315, 1988

    Article  PubMed  Google Scholar 

  4. Jones LR, Besch J.H.R.: Isolation of canine cardiac sarcolemmal vesicles. Meth Pharmacol 5: 1–12, 1984

    Google Scholar 

  5. Hansen O, Clausen T: Quantitative determination of Na+-K+-ATPase and other sarcolemmal components in muscle cells. Am J Physiol 254: 1–7, 1988

    Google Scholar 

  6. Schmidt TA, Kjeldsen K: Enhanced clearance of specifically bound digoxin from human myocardial and skeletal muscle samples by specific digoxin antibody fragments: Subsequent complete digitalis glycoside receptor (Na,K-ATPase) quantification. J. Cardiovasc Pharmacol 17: 670–677, 1991

    PubMed  Google Scholar 

  7. Schmidt TA, Holm Nielsen P, Kjeldsen K: No upregulation of digitalis glycoside receptor (Na,K-ATPase) concentration in human heart left ventricle samples obtained at necropsy after long term digitalisation. Cardiovasc Res 25: 684–691, 1991

    PubMed  Google Scholar 

  8. Schmidt TA, Allen PD, Colucci WS, Marsh JD, Kjeldsen K: No adaptation to digitalization as evaluated by digitalis receptor (Na,K-ATPase) quantification in explanted hearts from donors without heart disease and from digitalized recipients with end-stage heart failure. Am J Cardiol 71: 110–114, 1993

    Article  PubMed  Google Scholar 

  9. Ellingsen Ø, Holthe R, Svindland A, Aksnes G, Sejersted OM, Ilebekk A: Na,K-pump concentration in hypertrophied human hearts. Eur Heart J 15: 1184–1190, 1994

    PubMed  Google Scholar 

  10. Kjelsen K, Bjerregaard P, Richter EA, Thomsen PE, Nørgaard A: Na+,K+-ATPase concentration in rodent and human heart and skeletal muscle: Apparent relation to muscle performance. Cardiovasc Res 22: 95–100, 1988

    PubMed  Google Scholar 

  11. Nørgaard A, Kjeldsen K: Human myocardial Na,K-pumps in relation to heart disease. J Appl Cardiol 4: 239–245, 1989

    Google Scholar 

  12. Nørgaard A, Bjerregaard P, Baandrup U, Kjeldsen K, Reske Nielsen E, Thomsen PE: The concentration of the Na,K-pump in skeletal and heart muscle in congestive heart failure. Int J Cardiol 26: 185–190, 1990

    PubMed  Google Scholar 

  13. Shamraj OI, Grupp IL, Grupp G, Melvin D, Gradoux N, Kremers W, Lingrel JB, De Pover A: Characterisation of Na/K-ATPase, its isoforms, and the inotropic response to ouabain in isolated failing human hearts. Cardiovasc Res 27: 2229–2237, 1993

    PubMed  Google Scholar 

  14. Kjeldsen K, Grøn P: Age-dependent change in myocardial cardiac glycoside receptor (Na,K-pump) concentration in children. J Cardiovasc Pharmacol 15: 332–337, 1990

    PubMed  Google Scholar 

  15. Wettrell G, Andersson KE: Clinical pharmacokinetics of digoxin in infants. Clin Pharmacokinet 2: 17–31, 1977

    PubMed  Google Scholar 

  16. Schwinger RHG, Böhm M, Erdmann E: Effectiveness of cardiac glycosides in human myocardium with and without ‘downregulated’ β-adrenoceptors. J Cardiovasc Pharmacol 15: 692–697, 1990

    PubMed  Google Scholar 

  17. Morgan JP: Abnormal intracellular modulation of calcium as a major cause of cardiac contractile dysfunction. N Engl J Med 325: 625–632, 1991

    PubMed  Google Scholar 

  18. Schmidt TA, Bundgaard H, Larsen JS, Arendrup H, Kjeldsen K: Reduced left ventricular Na,K-ATPase concentration in symptomatic patients with chronic aortic valvular disease. J Mol Cell Cardiol 27: a239, 1995

    Google Scholar 

  19. O'Gorman DJ, Sheridan DJ: Abnormalities of the coronary circulation associated with left ventricular hypertrophy. Clin Sci 81: 703–713, 1991

    PubMed  Google Scholar 

  20. Beller GA, Conroy J, Smith TW: Ischaemia-induced alterations in myocardial (Na+ + K+)-ATPase and cardiac glycoside binding. J Clin Invest 57: 341–350, 1976

    PubMed  Google Scholar 

  21. Schwartz A, Wood JM, Allen JC, Bornet EP, Entman ML, Goldstein MA: Biochemical and morphologic correlates of cardiac ischaemia. I. Membrane systems. Am J Cardiol 32: 46–61, 1973

    PubMed  Google Scholar 

  22. Schmidt TA, Svendsen JH, Haunsø S, Kjeldsen K: Quantification of the total Na,K-ATPase concentration in atria and ventricles from mammalian species by measuring 3H-ouabain binding to intact myocardial samples. Stability to short term ischemia reperfusion. Basic Res Cardiol 85: 411–427, 1990

    PubMed  Google Scholar 

  23. Rasmussen HH, Okita GT, Hartz RS, Ten Eick RE: Inhibition of electrogenic Na+-pumping in isolated atrial tissue from patients treated with digoxin. J Pharmacol Exp Ther 252: 60–64, 1990

    PubMed  Google Scholar 

  24. Dørup I, Skajaa K, Thybo NK: Oral magnesium supplementation restores the concentrations of magnesium, potassium and sodium-potassium pumps in skeletal muscle of patients receiving diuretic treatment. J Int Med 233: 117–123, 1993

    Google Scholar 

  25. Schmidt TA, Holm Nielsen P, Kjeldsen K: Human skeletal muscle digitalis glycoside receptors (Na,K-ATPase) — importance during digitalization. Cardiovasc Drugs Ther 7: 175–181, 1993

    PubMed  Google Scholar 

  26. Schmidt TA, Bundgaard H, Olsesen HL, Secher NH, Kjeldsen K: Digoxin affects potassium homeostasis during exercise in patients with heart failure. Cardiovasc Res 29: 506–511, 1995

    Article  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Medicine B 2142, The Heart Centre, Rigshospitalet, National University Hospital, Blegdamsvej 9, DK-2100, Copenhagen ø, Denmark

    Henning Bundgaard & Keld Kjeldsen

Authors
  1. Henning Bundgaard
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Keld Kjeldsen
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Bundgaard, H., Kjeldsen, K. Human myocardial Na,K-ATPase concentration in heart failure. Mol Cell Biochem 163, 277–283 (1996). https://doi.org/10.1007/BF00408668

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF00408668

Keywords

Search

Navigation